| Literature DB >> 35764146 |
Stoimir Kolarević1, Adrienn Micsinai2, Réka Szántó-Egész3, Alena Lukács3, Margareta Kračun-Kolarević4, Ana Djordjevic4, Danijela Vojnović-Milutinović4, Jovana Jovanović Marić4, Alexander K T Kirschner5, Andreas A H Farnleitner6, Rita Linke7, Aleksandar Đukic8, Jovana Kostić-Vuković9, Momir Paunović4.
Abstract
Wastewater-based epidemiology (WBE) surveillance of COVID-19 and other future outbreaks is a challenge for developing countries as most households are not connected to a sewerage system. In December 2019, SARS-CoV-2 RNA was detected in the Danube River at a site severely affected by wastewaters from Belgrade. Rivers are much more complex systems than wastewater systems, and efforts are needed to address all the factors influencing the adoption of WBE as an alternative to targeting raw wastewater. Our objective was to provide a more detailed insight into the potential of SARS-CoV-2 surveillance in Serbian surface waters for epidemiological purposes. Water samples were collected at 12 sites along the Sava and Danube rivers in Belgrade during the fourth COVID-19 wave in Serbia that started in late February 2021. RNA was concentrated using Amicon Ultra-15 centrifugal filters and quantified using RT-qPCR with primer sets targeting nucleocapsid (N1 and N2) and envelope (E) protein genes. Microbiological (faecal indicator bacteria and human and animal genetic faecal source tracking markers), epidemiological, physicochemical and hydromorphological parameters were analysed in parallel. From 44 samples, SARS-CoV-2 RNA was detected in 31, but only at 4 concentrations above the level of quantification (ranging from 8.47 × 103 to 2.07 × 104 gc/L). The results indicated that surveillance of SARS-CoV-2 RNA in surface waters as ultimate recipients could be used as an epidemiological early-warning tool in countries lacking wastewater treatment and proper sewerage infrastructure. The performance of the applied approach, including advanced sampling site characterization to trace and identify sites with significant raw sewage influence from human populations, could be further improved by adaptation of the methodology for processing higher volumes of samples and enrichment factors, which should provide the quantitative instead of qualitative data needed for WBE.Entities:
Keywords: Faecal pollution; SARS-CoV-2; Serbia; Surface waters; Untreated wastewaters
Mesh:
Substances:
Year: 2022 PMID: 35764146 PMCID: PMC9232394 DOI: 10.1016/j.scitotenv.2022.156964
Source DB: PubMed Journal: Sci Total Environ ISSN: 0048-9697 Impact factor: 10.753
Sampling sites and characteristics of the closest wastewater sewer outlets relative to the sampling site (Master Plan of the Belgrade Sewerage System, 2011).
| Sampling spot | Coordinates | Distance from closest outlet | Sewer type | Average sewage flow rate | Wastewater load, p.e.(−) |
|---|---|---|---|---|---|
| S1 | 44°48′46.05″N | 60 | Combined | 17,500 | 74,800 |
| S2 | 44°47′59.21″N | 100 | Separate and combined | 94,250 | 537,000 |
| S3 | 44°49′23.75″N | 20 | Separate | 47,820 | 268,000 |
| S4 | 44°46′51.28″N | - | Separate and combined | 5000 | 20,000 |
| S5 | 44°47′34.71″N | 80 | Separate and combined | 5000 | 20,000 |
| S6 | 44°49′15.72″N | 250 | Separate | 7900 | 37,500 |
| S7 | 44°49′29.69″N | 30 | Combined | 46,650 | 246,000 |
| S7a | 44°49′25.6″N | 2000 | Combined | 46,650 | 246,000 |
| S7b | 44°49′50.1″N | 4570 | Combined | 46,650 | 246,000 |
| S8 | 44°49′47.99″N | 250 | Separate | 13,050 | 61,300 |
| S9 | 44°49′54.76″N | 620 | Separate | 13,050 | 61,300 |
| S9b | 44°50′22.6″N | 1800 | Separate | 13,050 | 61,300 |
p.e. – population equivalent, 1 p.e. = 60 gBOD5/day; BOD5–5-day biochemical oxygen demand.
- no precise data on wastewater outlets, estimated values.
Fig. 1Satellite images of sampling sites (Google Earth).
An overview of the water samples collected and processed in the 3rd and 4th COVID-19 waves.
| Sample group | Date of sampling | COVID-19 wave in RS | Frequency of sampling | Number of samples | Sampling sites |
|---|---|---|---|---|---|
| Group I | 10th December 2020 | 3rd | Multiple-hourly | 12 | S9 |
| Group II | 28th February 2021 | 4th | single grab | 6 | S7, S7a, S7b, S9, S9b |
| Group III | 9th March-28th May 2021 | 4th | 1–2 times per week | 19 | S9 |
| Group IV | 29th March-2nd April 2021 | 4th | single grab | 7 | S1, S2, S3, S4, S5, S6, S8 |
Results of RT-qPCR amplification shown as gc/L of SARS-CoV-2 target gene in Group I samples (calculation is based on N2 primer set) and observed quality assessment (above SLOD or above SLOQ).
| Sample code | Genetic region detected | gc/L | Quality assessment | SLOQ (gc/L) |
|---|---|---|---|---|
| B-1220-7.00 | N2 | 4.22E+03 | >SLOD | 1.44E+04 |
| B-1220-8.00 | N2 | 3.58E+03 | >SLOD | 1.44E+04 |
| B-1220-9.00 | N2 | 7.34E+03 | >SLOD | 1.44E+04 |
| B-1220-10.00 | N2 | 6.17E+03 | >SLOD | 1.44E+04 |
| B-1220-11.00 | N2 | 1.05E+04 | >SLOD | 1.93E+04 |
| B-1220-12.00 | N2 | 5.17E+03 | >SLOD | 1.02E+04 |
| B-1220-13.00 | N2 | 7.83E+03 | >SLOD | 1.02E+04 |
| B-1220-14.00 | N2 | 4.60E+03 | >SLOD | 1.02E+04 |
| B-1220-15.00 | – | – | – | |
| B-1220-16.00 | N2,E | 1.28E+04 | >SLOQ | 8.47E+03 |
| B-1220-17.00 | N2 | 6.56E+03 | >SLOD | 8.47E+03 |
| B-1220-18.00 | N2 | 8.97E+03 | >SLOQ | 8.47E+03 |
Results of RT-qPCR amplification shown as gc/L of SARS-CoV-2 target gene in Group II samples (calculation is based on the N2 primer set) and observed quality assessment (above SLOD or SLOQ).
| Sample code | Site | Genetic region detected | gc/L | Quality assessment | SLOQ (gc/L) |
|---|---|---|---|---|---|
| B-0221-0 | S7 us outlet | – | – | – | |
| B-0221-1 | S7 ds outlet | N2 | 1.18E+04 | >SLOD | 2.07E+04 |
| B-0221-2 | S7a | – | – | – | |
| B-0221-3 | S7b | – | – | – | |
| B-0221-4 | S9 | N2 | 5.66E+02 | >SLOD | 1.21E+04 |
| B-0221-5 | S9b | N2 | 1.05E+04 | >SLOD | 4.42E+04 |
Results of RT-qPCR amplification shown as gc/L of the SARS-CoV-2 target gene in Group III samples (calculation is based on the N2 primer set) and the observed quality of assessment (above SLOD and SLOQ).
| Sample code | Sampling date | Genetic region detected | gc/L | quality assessment | SLOQ (gc/L) |
|---|---|---|---|---|---|
| B-090321 | 3/9/21 | N2 | 1.50E+04 | >SLOQ | 8.47E+03 |
| B-120321 | 3/12/21 | – | – | – | |
| B-160321 | 3/16/21 | N2 | 1.12E+04 | >SLOD | 2.42E+04 |
| B-190321 | 3/19/21 | – | – | – | |
| B-220321 | 3/22/21 | N2 | 1.51E+04- | >SLOD | 1.76E+04 |
| B-250321 | 3/25/21 | N2 | 1.01E+04 | >SLOD | 2.40E+04 |
| B-290321 | 3/29/21 | N2,N1,E | 6.86E+03 | >SLOD | 2.85E+04 |
| B-020421 | 4/2/21 | N2,N1,E | 3.01E+04 | >SLOD | 2.85E+04 |
| B-050421 | 4/5/21 | – | – | – | |
| B-090421 | 4/9/21 | N2 | 1.52E+04 | >SLOD | 4.42E+04 |
| B-130421 | 4/13/21 | – | – | – | |
| B-160421 | 4/16/21 | N2 | 1.13E+03 | >SLOD | 1.21E+04 |
| B-190421 | 4/19/21 | – | – | – | |
| B-220421 | 4/22/21 | – | – | – | |
| B-010521 | 5/1/21 | N2,N1,E | 8.62E+04 | >SLOQ | 2.07E+04 |
| B-060521 | 5/6/21 | N2 | 1.88E+04 | >SLOD | 2.07E+04 |
| B-120521 | 5/12/21 | – | – | – | |
| B-200521 | 5/20/21 | – | – | – | |
| B-280521 | 5/28/21 | – | – | – | – |
Results of RT-qPCR amplification shown as gc/L of SARS-CoV-2 target gene in Group IV samples (calculation is based on the N2 primer set) and observed quality assessment (above SLOD and SLOQ).
| Sample code | Sampling date | Genetic region detected | gc/L | Quality assessment | SLOQ |
|---|---|---|---|---|---|
| S8 | 3/29/21 | N2,N1,E | 1.02E+04 | >SLOD | 2.85E+04 |
| S1 | 3/31/21 | N2,N1,E | 1.42E+04 | >SLOD | 2.85E+04 |
| S2 | 3/31/21 | N2,N1,E | 1.75E+04 | >SLOD | 4.23E+04 |
| S5 | 3/31/21 | N2,E | 1.03E+04 | >SLOD | 4.23E+04 |
| S4 | 3/31/21 | N2 | 1.25E+04 | >SLOD | 4.23E+04 |
| S3 | 3/31/21 | N2,N1,E | 1.05E+04 | >SLOD | 4.23E+04 |
| S6 | 4/2/21 | N2,N1,E | 3.73E+04 | >SLOD | 4.42E+04 |
Fig. 2Results of MST marker analyses for all samples expressed as marker equivalents (log (ME+1)/100 mL) for human- (BacHum), ruminant- (BacR) and pig- (Pig-2-Bac) associated genetic faecal markers.
Numbers of standard faecal indicator bacteria (E. coli and intestinal enterococci expressed as log MPN/100 mL) and the microbial source tracking marker BacHum expressed as log (ME+1)/100 mL.
| Group/site | BacHum | ||
|---|---|---|---|
| Leterature data | |||
| Raw WW | 6.1 | 4.8 | 8.6 |
| Treated WW | 3.8 | 3.4 | 6.4 |
| Danube-whole river | 2.4 | 1.5 | 3.8 |
| Danube-annual ds Belgrade | 3.5 | 2.9 | 5.0 |
| Group I | |||
| S9 | 5.9 | 5.1 | 8.1 |
| Group II | |||
| S7 us outlet | 3.2 | 2.6 | 5.0 |
| S7 ds outlet | 6.8 | 6.0 | 8.4 |
| S7a | 3.6 | 2.8 | 5.4 |
| S7b | 3.7 | 2.5 | 5.2 |
| S9 | 5.3 | 4.1 | 6.6 |
| S9b | 4.1 | 2.8 | 5.8 |
| Group III | |||
| S9 | 5.8 | 5.0 | 7.6 |
| Group IV | |||
| S1 | 6.1 | 5.2 | 8.1 |
| S2 | 7.2 | 6.5 | 9.1 |
| S3 | 5.9 | 4.8 | 7.6 |
| S4 | 5.5 | 3.8 | 7.0 |
| S5 | 5.1 | 3.6 | 6.7 |
| S6 | 6.0 | 5.1 | 7.7 |
| S8 | 6.5 | 5.1 | 7.7 |
Mayer et al. (2016).
Kirschner et al. (2017).
median value of multiple measurments.
single measurement.
Fig. 3Number of new COVID-19 cases in Serbia reported per day, sampling dates for Group I samples are marked in green, those for Group II are marked in blue, for Group III in red, and for Group IV in yellow (data retrieved from https://www.worldometers.info/coronavirus/country/serbia/).
Fig. 4Numbers of standard faecal indicators (EC – E. coli and IE – intestinal enterococci expressed as log MPN/100 mL) and microbial source tracking markers (BacHum expressed as log (ME+1)/100 mL) in water samples from Group I.